University Hospital of Ulm

Ulm 89081

2 studies enrolling now · 5 studies all time

What they study most

B-cell Chronic Lymphocytic Leukemia, Cholangiocarcinoma, Cholestasis, Colorectal Cancer, Gastric Cancers, Interstitial Lung Disease, Neoplasms, Pancreatic Cancer, Pancreatic Neoplasms, Scleroderma, Systemic, Sclerosis, Systemic, Systemic Scleroderma

Studies at this site

• Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells — Recruiting now
• BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours — Recruiting now
• Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung Disease — Stopped early
• A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy — Completed
• Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia — Stopped early